RENASANT CORP
For the period ended Dec 31, 2025. Filed Mar 2, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 2, 2026
RNST$40.19+0.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets at December 31, 2025 and
| December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Assets | ||
| Cash and due from banks | $299,592 | $198,408 |
| Interest-bearing balances with banks | 771,126 | 893,624 |
| Cash and cash equivalents | 1,070,718 | 1,092,032 |
| Securities held to maturity (net of allowance for credit losses of $32 at both December 31, 2025 and 2024) (fair value of $961,870 and $1,002,544, respectively) | 1,030,073 | 1,126,112 |
| Securities available for sale, at fair value (amortized cost of $2,635,495 and $968,927, respectively) | 2,560,818 | 831,013 |
| Loans held for sale, at fair value | 265,959 | 246,171 |
| Loans held for investment, net of unearned income | 19,047,039 | 12,885,020 |
| Allowance for credit losses | (293,955) | (201,756) |
| Loans, net | 18,753,084 | 12,683,264 |
| Premises and equipment, net | 465,141 | 279,796 |
| Other real estate owned, net | 15,191 | 8,673 |
| Goodwill | 1,405,840 | 988,898 |
| Other intangible assets, net | 146,612 | 14,105 |
| Bank-owned life insurance | 492,541 | 391,810 |
| Mortgage servicing rights, net | 65,271 | 72,991 |
| Other assets | 480,178 | 300,003 |
| Total assets | $26,751,426 | $18,034,868 |
| Liabilities and shareholders’ equity | ||
| Liabilities | ||
| Deposits | ||
| Noninterest-bearing | $5,043,960 | $3,403,981 |
| Interest-bearing | 16,429,110 | 11,168,631 |
| Total deposits | 21,473,070 | 14,572,612 |
| Short-term borrowings | 555,774 | 108,018 |
| Long-term debt | 499,756 | 430,614 |
| Other liabilities | 337,921 | 245,306 |
| Total liabilities | 22,866,521 | 15,356,550 |
| Shareholders’ equity | ||
| Preferred stock, $0.01 par value – 5,000,000 shares authorized; no shares issued and outstanding | — | — |
| Common stock, $5.00 par value – 250,000,000 and 150,000,000 shares authorized, respectively; 97,722,397 and 66,484,225.00 shares issued, respectively; 94,636,207 and 63,565,690 shares outstanding, respectively | 488,612 | 332,421 |
| Treasury stock, at cost, 3,086,190 and 2,918,535 shares, respectively | (103,494) | (97,196) |
| Additional paid-in capital | 2,392,997 | 1,491,847 |
| Retained earnings | 1,196,522 | 1,093,854 |
| Accumulated other comprehensive loss, net of taxes | (89,732) | (142,608) |
| Total shareholders’ equity | 3,884,905 | 2,678,318 |
| Total liabilities and shareholders’ equity | $26,751,426 | $18,034,868 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.